| Recombinant human tgG molecules lacking Fc receptor I binding and monocyte triggering activities KL Armour, MR Clark, AG Hadley, LM Williamson European journal of immunology 29, 2613-2624, 1999 | 524 | 1999 |
| Differential binding to human FcγRIIa and FcγRIIb receptors by human IgG wildtype and mutant antibodies KL Armour, JGJ van de Winkel, LM Williamson, MR Clark Molecular immunology 40 (9), 585-593, 2003 | 190 | 2003 |
| Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies KL Armour, HJ Hansen CA Patent 2,200,868, 2010 | 182* | 2010 |
| CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies HJ Hansen, KL Armour US Patent 5,874,540, 1999 | 182* | 1999 |
| Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies KL Armour, HJ Hansen WO Patent App. PCT/US1995/011,964, 1995 | 182* | 1995 |
| CDR-Grafted type III anti-cea humanized mouse monoclonal antibodies KL Armour, HJ Hansen EP Patent App. 20,080,008,840, 1995 | 182* | 1995 |
| Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors AM Scott, D Geleick, M Rubira, K Clarke, EC Nice, FE Smyth, E Stockert, ... Cancer research 60 (12), 3254-3261, 2000 | 151 | 2000 |
| Specificity analysis of blood group Lewis-y (Le (y)) antibodies generatedagainst synthetic and natural Le (y) determinants K Kitamura, E Stockert, P Garin-Chesa, S Welt, KO Lloyd, KL Armour, ... Proceedings of the National Academy of Sciences 91 (26), 12957-12961, 1994 | 141 | 1994 |
| High affinity humanized anti-CEA monoclonal antibodies WHK Anderson, PR Tempest, FJ Carr, WJ Harris, K Armour US Patent App. 09/974,498, 2001 | 71* | 2001 |
| Developing recombinant HPA-1a–specific antibodies with abrogated Fcγ receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia C Ghevaert, DA Wilcox, J Fang, KL Armour, MR Clark, WH Ouwehand, ... The Journal of clinical investigation 118 (8), 2929-2938, 2008 | 67 | 2008 |
| High affinity humanized anti-CEA monoclonal antibodies WHK Anderson, PR Tempest, FJ Carr, WJ Harris, K Armour US Patent 6,333,405, 2001 | 66* | 2001 |
| Recombinant human anti-Lewis Y antibodies TP Wallace, KL Armour, FJ Carr, LJ Old, E Stockert, S Welt, K Kitamura, ... US Patent 6,310,185, 2001 | 66 | 2001 |
| High affinity humanized anti-CEA monoclonal antibodies WHK Anderson, PR Tempest, FJ Carr, WJ Harris, K Armour US Patent App. 09/974,051, 2001 | 66* | 2001 |
| HIGH AFFINITY HUMANIZED ANTI-CEA MONOCLONAL ANTIBODIES WHK Anderson, PR Tempest, FJ Carr, WJ Harris, K Armour EP Patent 1,056,859, 2000 | 66* | 2000 |
| HIGH AFFINITY HUMANIZED ANTI-CEA MONOCLONAL ANTIBODIES W ANDERSON, K Henry, P TEMPEST, F CARR, W HARRIS, K ARMOUR WO Patent 1,999,043,817, 1999 | 66* | 1999 |
| High affinity humanized anti-cea monoclonal antibodies WHK Anderson, K Armour, FJ Carr, WJ Harris, PR Tempest CA Patent App. 2,321,947, 1998 | 66* | 1998 |
| High affinity humanized anti-cea monoclonal antibodies WHK Anderson, K Armour, FJ Carr, WJ Harris, PR Tempest EP Patent App. 19,980,907,630, 1998 | 66* | 1998 |
| Fc Gamma Receptor 3A Polymorphism and Risk for HIV-Associated Cryptococcal Disease S Rohatgi, S Gohil, MH Kuniholm, H Schultz, C Dufaud, KL Armour, ... mBio 4 (5), e00573-13, 2013 | 63 | 2013 |
| High affinity humanized anti-CEA monoclonal antibodies WHK Anderson, PR Tempest, FJ Carr, WJ Harris, K Armour US Patent 6,417,337, 2002 | 62* | 2002 |
| Human IgG isotypes and activating Fcγ receptors in the interaction of Salmonella enterica serovar Typhimurium with phagocytic cells YS Goh, AJ Grant, O Restif, TJ McKinley, KL Armour, MR Clark, ... Immunology 133 (1), 74-83, 2011 | 61 | 2011 |
Mike ClarkRetired (30th Sept 2014) as Reader in Therapeutic and Molecular Immunology, Cambridge UniversityVerified email at cam.ac.uk
